CDKN1A and cancer: Regarding the non-coding RNAs, LINC00378 has Cyclin-Dependent Kinase Inhibitor 1A (CDKN1A) as the main target and is linked to different types of cancers, while MIR3169 targets genes that are mainly involved in the p53 signaling pathway.